A decision is made: no AstraZeneca vaccines for people under 60 in the Netherlands

Vaccinations of people under the age of 60 with the AstraZeneca vaccine will not be resumed in the Netherlands for now. 

The Minister for Health, Hugo de Jonge, announced this yesterday after receiving advice from the Health Council, reports RTL Nieuws. People under the age of 60 who have already received their first AstraZeneca shot can still get the second one. 

Benefits outweigh the risks

While the European Medicines Agency concluded that thrombosis is likely a very rare side effect of the vaccine, it also believes that the benefits of the vaccine outweigh the risks

This is especially the case for older age groups. As a result, those above 60 can receive the AstraZeneca vaccine because the risks associated with the coronavirus are much higher for this age group than the risks of serious side effects from the vaccine. 

Young women and AstraZeneca

The risks are less balanced for young women in particular. For them, the risk of suffering serious side effects from the vaccine is potentially higher than the risk of dying from coronavirus, reports NU.nl.

“A chance [of contracting serious side effects from the vaccine] of one in a few hundred thousand is of course very small. But young women also have a very small chance of dying from corona, about one in a half-million or one in a million. And then that balance is suddenly very different,” says Bart-Jan Kullberg, President of the Health Council of the Netherlands.  

He adds that “the EMA does not give advice to whom you should give which vaccine. The EMA is examining whether that vaccine is still permissible at all.”

No smooth sailing

The story of the AstraZeneca vaccine in the Netherlands has been a turbulent one. 

In mid-March, the Dutch government decided to pause the vaccine until at least March 28 due to fears over the increased risk of blood clots. Shortly after that, the vaccine was set to be resumed

There has also been considerable criticism from thrombosis experts about not being involved in the decisions around the AstraZeneca vaccine. “The decision to stop came like a bolt from the blue,” says thrombosis expert Saskia Middeldorp. 

How do you feel about this development? Let us know your thoughts in the comments below!

Feature Image: Aaron Sousa/Unsplash

Jana Vondráčková 🇨🇿
Jana Vondráčková 🇨🇿
Originally from the Czech Republic, Jana moved to the Netherlands for her studies. She fell in love with the local biking culture, and you’ll see her drifting through the streets of Rotterdam on her pink bike even in the worst possible weather (think rain, snow, hail, or all three). Besides advocating for Rotterdam as the best Dutch city, she likes to wander around with a camera in her hand.

2 COMMENTS

  1. is AztraZeneca vaccine the only vaccine available in The Netherlands?
    why they don’t purchase other vaccine from other manufacturer like Johnson & Johnson
    and Pfizer/BioNtech?

    • Hey willie, great question! Pfizer/Biotech vaccinations are already being given out in the Netherlands, and the Janssen/Johnson & Johnson vaccine has been preordered.😊

Leave a Reply to Chloe Lovatt Cancel reply

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related posts

Latest posts

Swimming in Amsterdam’s canals: what you need to know

Fancy a swim in a canal in Amsterdam? Maybe think twice. While those dreamy canals may look perfect for a refreshing dip, they're full...

Endless TikTok queues might force this Amsterdam business to shut down

Going viral on TikTok makes you big news, with bigger queues. That's the case for tiny chip shop Fabel Friet in Amsterdam, but now...

Pro-Palestine ‘protest camp’ at University of Amsterdam ends in violence and 125 arrests

Yesterday afternoon, protesters in Amsterdam set up a 'Gaza Solidarity Encampment' on the Roeterseiland campus of the University of Amsterdam (UvA). The protest ended...

It's happening

Upcoming events

The latest Dutch news.
In your inbox.